Month: November 2025
-
Federal Circuit tells petitioners that IPR denials are unreviewable regardless of reliance on agency guidance in place at time of filing
A precedential decision reinforces the unreviewability of the USPTO Director’s decisions to deny (or vacate a decision to institute) inter partes reviews.
-
‘With great power comes great danger’: patent professionals warn against misuse of AI
Several panelists at the 12th Annual IP Dealmakers U.S. shared their concerns about the use of AI in every step of the patent lifecycle, warning that hallucinations, data poisoning, and the lack of human factor are “real” problems.
-
‘Striking’ and ‘extremely rare’: Japanese patent community reacts to USPTO Director Squires Nintendo patent reexamination order
Sources in the Japanese patent community tell ip fray that a USPTO reexamination order over a Nintendo patent signals heightened attention of claims that may overreach into broad gameplay mechanics – although the order will have no impact on Nintendo’s ongoing patent infringement litigation against Pocketpair in Japan.
-
Judge appears unconvinced of Samsung’s U.S. FRAND/antitrust complaint against ZTE; Samsung’s counsel hopes for leave to amend
Samsung is pursuing FRAND claims in multiple jurisdictions around the globe, one of which is the U.S., where its complaint is at a high risk of dismissal.
-
UPC CoA: translation of specification presumed accurate if it formed basis of EPO examination; court can decide added matter even without written argument
The UPC’s CoA affirmed the Dusseldorf LD’s finding of invalidity over added matter.
-
UK Supreme Court will hear Apple’s appeal of Optis’s $700M win with cast of characters familiar from Unwired: roller coaster ride?
Three of the questions for review relate to how UK courts can arrive at a FRAND rate, and one to the implications for parallel cases in foreign jurisdictions.
-
Boehringer wins PI against Dr. Reddy’s that blocks generic empagliflozin (Jardiance) sales in UK pending October 2026 trial: patent thickets work
In some jurisdictions it pays off for Boehringer Ingelheim to have created a patent thicket around empaglifozin (Jardiance) involving use and formulation patents.
-
Warner Bros. Discovery obtained UK anti-antisuit/anti-AILI injunction against Nokia on Monday; patent infringement litigation started on Saturday
The antisuit injunction wars between the UK judiciary and other jurisdictions keep escalating.
-
Nokia’s new Chief Licensing Officer for New Segments comes from InterDigital: Tejas Shah, dealmaker and patent valuation expert
Mr. Shah has a strong track record in licensing and appears to be leaving InterDigital on a very positive note.
-
OPPO licenses 4G and 5G patents to unnamed Chinese automaker engaged in “overseas market expansion”, following similar deal with VW
OPPO owns one of the top 10 cellular SEP portfolios and has now, for the second time, announced a 4G/5G license agreement with a car maker.